Estimated 10-year Global CVD Risk: >30%*

Risk Category: High Risk*

Estimated Vascular Age: >80 Years

CTN should initially receive and ACEi or ARB2.3 as she is an individual with Stage 1 ABPM and Type 2 diabetes

Beta-blockers are effective for reducing blood pressure but other antihypertensives are usually more effective for reducing the incidence of stroke, myocardial infarction, and cardiovascular mortality, especially in the elderly. CTN has risk of stroke or heart attack in next 10 years so another hypertension medication would be preferable.

stage 2 would involve starting on calcium channel blockers or a thiazide-like diuretic

if hypertension persists, both should be prescribed

LDL <100 mg/dL (<2.59 mmol/L)
Non-HDL <130 mg/dL (<3.37 mmol/L)

CCS (2009)Treatment Targets

LDL <2 mmol/L (<77 mg/dL) or ≥50 % decrease in LDL-C
apoB <0.8 g/L (80 mg/dL)

ESC (2007, see Info for more)Treatment Targets

LDL <2-2.5 mmol/L (<80-100 mg/dL)
TChol <4-4.5 mmol/L (<155-175 mg/dL)

Estimated 10-year Global CVD Risk

>30%*

Risk Category

High Risk*

Estimated Vascular Age

>80 Years*

QRisk -

Risk of having a heart attack or stroke within the next 10 years is:

39.3%